A series of new compounds were prepared under mild reaction conditions using click reaction of 11-azaartemisinin and various azides. All the synthesized compounds were fully characterized by spectral data and evaluated for their cytotoxic activity against KB and HepG2 cell lines. All synthesized artemisinin derivatives are more active than 11-azaartemisinin. Thirteen of the synthesized compounds displayed good cytotoxic activity against two human cancer cell lines, KB and HepG2, with half maximal inhibitory concentration values in a range of 4.27–70.40 μM. The most active derivative was the best to both KB and HepG2 cell lines with IC50 value of 10.18 and 4.27 μM, respectively.
Similar content being viewed by others
References
WHO Global Cancer report. http://www.who.int/cancer/en/, Accessed March 9, 2021.
Chin. Med. J. (Engl.) 1979, 92, 811.
Klayman, D. L. Science 1985, 228, 1049.
Li, Y.; Wu, Y.-L. Curr. Med. Chem. 2003, 10, 2197.
Miller, L. H.; Su, X. Cell 2011, 146, 855.
Posner, G. H. Expert Opin. Ther. Pat. 1998, 8, 1487.
Visser, B. J.; Wieten, R. W.; Kroon, D.; Nagel, I. M.; Bélard, S.; van Vugt, M.; Grobusch, M. P. Malaria J. 2014, 13, 463.
Wells, T. N. C.; van Huijsduijnen, R. H.; Voorhis, W. C. V. Nat. Rev. Drug Discovery 2015, 14, 424.
Muangphrom, P.; Seki, H.; Fukushima, E. O.; Muranaka, T. J. Nat. Med. 2016, 70, 318.
Tilley, L.; Straimer, J.; Gnädig, N. F.; Ralph, S. A.; Fidock, D. A. Trends Parasitol. 2016, 32, 682.
Lai, H. C.; Singh, N. P.; Sasaki, T. Invest. New Drugs 2013, 31, 230.
Ho, W. E.; Peh, H. Y.; Chan, T. K.; Wong, W. S. F. Pharmacol Ther. 2014, 142, 126.
Goodrich, S. K.; Schlegel, C. R.; Wang, G.; Belinson, J. L. Future Oncol. 2014, 10, 647.
Das, A. K. Ann. Med. Health Sci. Res. 2015, 5, 93.
Singh, N. P.; Lai, H. Life Sci. 2001, 70, 49.
Yan, X.; Yu, Y.; Ji, P.; He, H.; Qiao, C. Eur J. Med Chem. 2015, 102, 180.
Xu, C.-C.; Wu, J.-J.; Xu, T.; Yao, C.-H.; Yu, B.-Y.; Liu, J.-H. Eur. J. Med Chem. 2016, 123, 763.
Torok, D. S.; Ziffer, H.; Meshnick, S. R.; Pan, X. Q.; Ager A. J. Med. Chem. 1995, 38, 5045.
Singh, A. S.; Verma, V. P.; Hassam, M.; Krishna, N. N.; Puri, S. K.; Singh, C. Org. Lett. 2008, 10, 5461.
Bonandi, E.; Christodoulou, M. S.; Fumagalli, G.; Perdicchia, D.; Rastelli, G.; Passarella, D. Drug Discovery Today 2017, 22, 1572.
Phillips, O. A.; Udo, E. E.; Ali, A. A. M.; Al-Hassawi, N. Bioorg. Med. Chem. 2003, 11, 35.
Ferreira, M. D. L. G.; Pinheiro, L. C. S.; Santos-Filho, O. A.; Peçanha, M. D. S.; Sacramento, C. Q.; Machado, V.; Ferreira, V. F.; Souza, T. M. L.; Boechat N. Med. Chem. Res. 2014, 23, 1501.
Baraldi, P. G.; Pavani, M. G.; Nuñez, M. D. C.; Brigidi, P.; Vitali, B.; Gambari, R.; Romagnoli, R. Bioorg. Med. Chem. 2002, 10, 449.
Jana, S.; Iram, S.; Thomas, J.; Liekens, S.; Dehaen, W. Bioorg. Med. Chem. 2017, 25, 3671.
Pham, H. T.; Thuy, G. L. N.; Thi, T. A. D.; Thi, P. H.; Nguyen, T. A.; Nguyen, T. H.; Nguyen, T. D.; Ngo, H. T.; Le, T. A.; Nguyen, T. V. Chem. Heterocycl. Compd. 2020, 56, 1167. [Khim. Geterotsikl. Soedin. 2020, 56, 1167.]
Tăbăcaru, A.; Furdui, B.; Ghinea, I. O.; Cârâc, G.; Dineca, R. M. Inorg. Chim. Acta. 2017, 455, 329.
Haynes, R. K.; Wong, H. N.; Lee, K. W.; Lung, C. M.; Shek, L. Y.; Williams, I. D.; Croft, S. L.; Vivas, L.; Rattray, L.; Stewart, L.; Wong, V. K. W.; Ko, B. C. B. Chem. Med. Chem. 2007, 2, 1464.
Tu, Y. Nat. Med. 2011, 17, 1217.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Khimiya Geterotsiklicheskikh Soedinenii, 2021, 57(10), 1037–1044
Supplementary Information
ESM 1
(PDF 9928 kb)
Rights and permissions
About this article
Cite this article
Nguyen, D.T., Ngo, T.H., Tran, H.T. et al. Synthesis and Anticancer Activity of 11-azaartemisinin Derivatives Bearing 1,2,3-triazole Moiety. Chem Heterocycl Comp 57, 1037–1044 (2021). https://doi.org/10.1007/s10593-021-03019-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10593-021-03019-w